Financials

  • Market Capitalization 3.99 M
  • Employee 3
  • Founded 2010
  • CEO N/A
  • Website www.silopharma.com
  • Headquarter Nevada, United States
  • FIGI BBG002D1DZ06
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.05
Rapporto prezzo/fatturato
2.64

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4974
REVB
Revelation Biosciences, Inc. - Common Stock
1.05 USD+1.94%-4.55%+5.00%-23.91%4.18 M USD
4978
TCRT
Alaunos Therapeutics, Inc. - Common Stock
1.61 USD-3.01%-9.04%-12.97%-39.68%4.09 M USD
4989
MBIO
Mustang Bio, Inc. - Common Stock
0.54 USD-1.82%-5.26%-8.47%-37.79%3.91 M USD
4995
PHGE
BiomX Inc. COmmon Stock
0.14 USD+7.69%+7.69%-22.22%-97.39%3.74 M USD

Notizie